The first secondary outcome in the hierarchy (major adverse kidney disease events) occurred in 403 participants (2.1 events per 100 person-years) in the semaglutide group and 435 participants (2.3 events per 100 person-years) in the placebo group (95% CI, 0.80-1.05
Both excess and deficient levels of cortisol can disrupt the methylation cycle and affect the body's ability to detoxify harmful substances
Therefore, the nutrigenomic findings should be interpreted as indirect indicators of gut barrier modulation
Tirzepatide and Telemedicine: Convenient Access to Care To make weight loss treatments as accessible as possible, we offer Telehealth consultations for patients interested in Tirzepatide and other medical weight loss options
Although GLP-1s can be an effective tool, they dont work in a silo
Rare but serious side effects include pancreatitis, gallbladder complications, and thyroid concerns